BBIO (bridgebio.com) Earnings per share growth this year

Official company branding of BridgeBio Corp (BBIO)

Despite the risks of international instability and challenges with global trials, the GURU.Markets portal features a chart of annual earnings per share dynamics, where the current value is 28.80. BridgeBio Pharma is currently scaling its first genetic blockbuster by establishing a distribution network and developing partnerships with pharma behemoths to co-finance innovative research.

BBIO (bridgebio.com) Earnings per share growth in current year history from 07/04/2022 to 11/13/2026

Financial and market metric breakdowns for BridgeBio Pharma, Inc. (BBIO)

- stock value and consensus price forecast:
Market Price BridgeBio Pharma|BBIO - Analyst Consensus Forecast
- business market valuation indicators:
Market Capitalization BridgeBio Corp|BBIO - Real Price to Acquire Entire Company
- book capitalization information:
Accounting Value of a Share BridgeBio|BBIO - Company Book Value|Market Capitalization to Net Assets bridgebio.com|BBIO - Company Total Assets
- debt and solvency information:
All Debt to Shareholders' Equity Ratio BridgeBio Pharma, Inc.|BBIO - Long-Term Debt to Capital|Short-Term Debt to Capital bridgebio.com|BBIO - Company Debts|Debt to Net Assets Ratio BridgeBio Corp|BBIO - Company Long-Term Debt|Company Current Liabilities BridgeBio|Quick Ratio bridgebio.com
- net income and valuation multiples indicators:
BBIO - Net Profit|Expected Profit BridgeBio Pharma, Inc.|BBIO - Price to Earnings Ratio|Future Price to Earnings Multiple BridgeBio Corp|BBIO - PEG Multiple|Total Company Value to Operating Income Before Depreciation Ratio BridgeBio Corp|BBIO - Operating profit EBITDA|Earnings per share for the last 12 months BridgeBio|BBIO - Net earnings per share (EPS TTM)|Net earnings per share growth for the trailing year bridgebio.com|BBIO - Earnings growth in current year|Expected net earnings per share growth next year BridgeBio Pharma, Inc.
- revenue and sales proceeds data:
BBIO - Revenue and Sales Volume|Company Projected Revenue BridgeBio Pharma|BBIO - P/S Multiple|Market Cap to Expected Sales Ratio BridgeBio Corp
Basic company analysis:BridgeBio Pharma (BBIO)
Manufactured products of BridgeBio Pharma, Inc.

To assess the issuer's financial stability, the trend of net income per share is utilized, where the percentage difference between current and previous EPS values reflects the business scaling rate. By analyzing the relative change in EPS compared to the same period last year, an investor can gauge the monetization of acoramidis and the effectiveness of cash flow management at BridgeBio Pharma, Inc. (BBIO) as it moves toward regulatory approvals.

Main competitors

Earnings per share growth rate in current year Vertex Pharmaceuticals Incorporated (VRTX)|ALNY (Alnylam Inc.) - Earnings growth in current year|Earnings per share growth this year INSM (Insmed Corp)|Net earnings per share growth this year UTHR (United Therapeutics)|BMRN (biomarin.com) - Earnings per share increase in current year|Earnings per share growth in current year BGM Group BGM|COGT (Cogent Biosciences Inc) - Earnings per share trend in current year|Xeris Biopharma Inc - Earnings growth in current year|Earnings per share increase in current year KROS (Keros Corp)|ARCT: Earnings growth in current year|etonpharma.com (ETON) - Earnings growth in current year|Earnings per share growth in current year Kamada|FULC: Earnings per share increase in current year|Earnings per share growth in current year Abeona Therapeutics (ABEO)|Net earnings per share growth this year mereobiopharma.com MREO|Earnings growth in current year PLX (Protalix BioTherapeutics)|Earnings growth in current year Pliant Therapeutics Inc PLRX|Applied Therapeutics - Earnings growth in current year|RNTX: Earnings per share growth in current year|gelteq.com (GELS) - Earnings per share growth in current year|Aytu BioPharma - Earnings per share increase in current year|CMMB (Chemomab Therapeutics Ltd) - Earnings growth in current year|SRx Health (SRXH) - Expected net earnings per share growth this year|Earnings growth in current year PLRZ|zentaris.com - Earnings per share growth this year|Earnings growth in current year CYTH (CTD Holdings)|Net earnings per share change in current year Inozyme Pharma Inc.|Reneo Pharmaceuticals - Earnings growth in current year|Earnings per share growth rate in current year cosciensbio.com